Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I
LungMAP-S1400I 研究评估了随机分配接受纳武利尤单抗联合伊匹木单抗治疗与单用纳武利尤单抗治疗的患者的生活质量结果和风险预测。
期刊:Jnci-Journal of the National Cancer Institute
影响因子:7.2
doi:10.1093/jnci/djad003
Unger, Joseph M; Qian, Lu; Redman, Mary W; Tavernier, Susan S; Minasian, Lori; Sigal, Ellen V; Papadimitrakopoulou, Vassiliki A; Leblanc, Michael; Cleeland, Charles S; Dzingle, Samuel A; Summers, Thomas J; Chao, Herta; Madhusudhana, Sheshadri; Villaruz, Liza; Crawford, Jeffrey; Gray, Jhanelle E; Kelly, Karen L; Gandara, David R; Bazhenova, Lyudmila; Herbst, Roy S; Gettinger, Scott N; Moinpour, Carol M
